346 related articles for article (PubMed ID: 15196881)
1. CRH, stress, and major depression: a psychobiological interplay.
Claes SJ
Vitam Horm; 2004; 69():117-50. PubMed ID: 15196881
[TBL] [Abstract][Full Text] [Related]
2. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
3. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
4. [Stress and depression: clinical, neurobiological and genetical perspectives].
Claes SJ
Tijdschr Psychiatr; 2009; 51(8):551-7. PubMed ID: 19658067
[TBL] [Abstract][Full Text] [Related]
5. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
6. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
7. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
Steimer T; Python A; Schulz PE; Aubry JM
Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
[TBL] [Abstract][Full Text] [Related]
8. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
O'Kane M; Murphy EP; Kirby B
Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
10. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
11. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
12. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
[TBL] [Abstract][Full Text] [Related]
13. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
Haefner S; Baghai TC; Schule C; Eser D; Spraul M; Zill P; Rupprecht R; Bondy B
Neuropsychobiology; 2008; 58(3-4):154-62. PubMed ID: 19088492
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
15. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females.
Shea A; Walsh C; Macmillan H; Steiner M
Psychoneuroendocrinology; 2005 Feb; 30(2):162-78. PubMed ID: 15471614
[TBL] [Abstract][Full Text] [Related]
16. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
17. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
[TBL] [Abstract][Full Text] [Related]
18. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
19. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
[TBL] [Abstract][Full Text] [Related]
20. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited.
Engelmann M; Landgraf R; Wotjak CT
Front Neuroendocrinol; 2004; 25(3-4):132-49. PubMed ID: 15589266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
